Jefferies Downgrades Gentiva Health Services (GTIV) to Hold
Tweet Send to a FriendGet Alerts GTIV Hot Sheet
Price: $11.29 -3.17%
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 2 | New: 2
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 2 | New: 2
Trade GTIV Now!
Jefferies downgraded Gentiva Health Services (NASDAQ: GTIV) from Buy to Hold and lowers their price target from $34 to $21.
The firm cited, "... our belief that ongoing reimbursement risk will provide a continued overhang on the sector that will keep investors on the sidelines until reimbursement visibility improves."
For more ratings news on Gentiva Health Services click here and for the rating history of Gentiva Health Services click here.
Shares of Gentiva Health Services closed at $18.46 yesterday, with a 52 week range of $18.16-$29.21.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm cited, "... our belief that ongoing reimbursement risk will provide a continued overhang on the sector that will keep investors on the sidelines until reimbursement visibility improves."
For more ratings news on Gentiva Health Services click here and for the rating history of Gentiva Health Services click here.
Shares of Gentiva Health Services closed at $18.46 yesterday, with a 52 week range of $18.16-$29.21.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BofA/Merrill Lynch Downgrades Cliffs Natural Resources (CLF) to Underperform
- Keefe, Bruyette & Woods Downgrades Lincoln National (LNC) to Market Perform
- UPDATE: Raymond James Downgrades Gevo, Inc. (GEVO) to Market Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Jefferies & CoLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

